Education efforts among providers, payer, and patients can help answer the fundamental and important questions raised by the use of real-world data, said Viraj Narayanan, MBA, vice president of Life Sciences at COTA Healthcare.
Education efforts among providers, payer, and patients can help answer the fundamental and important questions raised by the use of real-world data, said Viraj Narayanan, MBA, vice president of Life Sciences at COTA Healthcare.
Transcript:
What is the adoption curve like for using real-world data and how do you get more people comfortable with using real-world data?
The idea of using real world data for regulatory purposes is brand new, and like anything brand new, it should be treated and assessed like that. What we see at COTA is that there's certainly a landscape of sponsors, laggards, those in the middle, and the pioneers. The pioneers are adopting real-world data today and considering how do we actually redesign or consider bringing a clinical trial to the FDA or EMA, differently with real-world data. Those sponsors are using considerations like a single arm trial, and using a comparator cohort with real-world data. For those that are in the middle, or the laggards, a lot of the work that we see that needs to be done is frankly, the education because it's something new. So questions that we hear all the time is why isn't this real-world data the same as my clinical trial data? Why isn't data captured in a reliable format? Why aren't the patients the same? How do we create a matching cohort, from our clinical trial data to the real world data? Is the data going to have the relevant endpoints that we need in our clinical trial relative to the real-world? These are really fundamental, important questions. It's not that for those that aren't adopting, they're not thinking through these questions. I think we just need a lot of education work, frankly, across sponsors, regulators, real-world data companies to help answer those questions. That validation work will really help pave the way for how this data can be used.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More